Corton Capital’s Bioventus BVS Stock Holding History

Corton Capital’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,766	Closed	-$35.9K	–	331
2022 Q4	$35.9K	Buy	+13,766	New	+$60.1K	0.03%	295

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Corton Capital's BVS Position: Q1 2023 in Review

Corton Capital sold out of Bioventus (BVS) in Q1 2023, closing a stake of 13,766 shares — an estimated $35.9K sold.

Corton Capital first reported a position in BVS in Q4 2022 and held it in 1 quarter. The position peaked at $35.9K in Q4 2022. 71 funds tracked by Wall St. Rank hold BVS as of Q1 2023.

Corton Capital reported no remaining Bioventus position as of Q1 2023 after selling out during the quarter.
Corton Capital sold 13,766 Bioventus shares in Q1 2023, an estimated $35.9K.
Corton Capital first reported a position in Bioventus in Q4 2022 and held it in 1 quarter.
Corton Capital's Bioventus position peaked at $35.9K in Q4 2022.
71 funds tracked by Wall St. Rank held Bioventus as of Q1 2023.

Based on Corton Capital's 13F filing for Q1 2023, filed 15 May 2023.